Date | Title | Description | |
---|---|---|---|
16 Feb 2022 | On business and financial situation | Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years | Download |
03 Nov 2021 | On buy-back programmes | The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. | Download |
16 Jul 2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | Download |
22 Jun 2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | Download |
22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
07 Jan 2025 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the fourth quarter of 2024 | Download |
07 Nov 2024 | On P&L | A correction to the English version of a document is reported. | Download |
03 Oct 2024 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the third quarter of 2024 | Download |
12 Sep 2024 | Other relevant information | The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure. | Download |
01 Aug 2024 | Other relevant information | The Company has agreed to execute the share capital reduction approved by the 2024 Ordinary General Meeting to amortize treasury shares, among which those acquired in the framework of the own shares repurchase program. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
08 May 2019 | Information on P&L | ROVI releases the first quarter 2019 results presentation | Download |
08 May 2019 | Information on P&L | ROVI releases the press release related to the first quarter 2019 financial results | Download |
07 May 2019 | Liquidity contracts and specialists | ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A. | Download |
30 Apr 2019 | Liquidity contracts and specialists | ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U. | Download |
11 Apr 2019 | Strategic agreements with third parties | The Company releases the press release related to the marketing agreement of Tetridar® in Spain | Download |